Fund Evaluator:
Clockwise U.S. Core Equity ETF (TIME)Equity
Global Asset Class
U.S. Equity
Fund Group
Large Growth
Category
$0.000
NAV (as of )
$0.00
Minimum Initial
0.96% F
Expense Ratio
$15 Mil
Assets
Open
Status
na
12b-1 Fee
4.52%
TTM Yield
0.00%
Max Load
1555%
Portfolio Turnover
Best Performing in Large Growth Over the Last Year
| 39.6% | Tanaka Growth (TGFRX) |
| 35.2% | Fidelity Advisor OTC Z (FOTJX) |
| 35.1% | Fidelity OTC (FOCPX) |
| 34.8% | Chase Growth N (CHASX) |
| 27.3% | Fidelity Advisor Focused Stock Z (FSFOX) |
Data as of 7/31/2026
-0.9% B
1-Mo Return
2.9% C
3-Mo Return
6.8% C
YTD Return
15.3% C
1-Yr Return
19.8% C
3-Yr Return
na
5-Yr Return
1.03 D
Category Risk Index
1.55
Total Risk Index
Fund Details
Fund Family
Clockwise Capital LLC
Inception Date
1/27/2022
Share Class Type
Equity Investment Style
Large-Cap
Blend
Bond Investment Style
na
Socially Responsible Fund
No
Index Fund
No
Benchmark Index
S&P 500 (TR) (1970): 100%
Additional Fund Details
Clockwise U.S. Core Equity ETF Overview
TIME Trailing NAV Total Returns Data as of 7/31/26
| Last Month |
Last Quarter |
Ann'l. 1Yr |
Ann'l. 3Yr |
Ann'l. 5Yr |
Ann'l. 10Yr |
|
| TIME Return (NAV) | -0.9% | 2.9% | 15.3% | 19.8% | na | na |
| TIME Grade | B | C | C | C | na | na |
| +/- Category | 2.1% | 1.2% | 6.3% | 1.7% | na | na |
| Large Growth Avg | -3.1% | 1.7% | 9.1% | 18.1% | 8.7% | 15.4% |
| TIME Tax Cost Ratio | na | na | 3.0% | 5.2% | na | na |
TIME Annual NAV Total ReturnsData as of 7/31/26
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
| TIME Return (NAV) | 6.8% | 9.6% | 36.6% | 57.8% | na | na | na | na | na | na | na |
| TIME Grade | C | F | A | A | na | na | na | na | na | na | na |
| +/- Category | 3.0% | -6.1% | 7.0% | 19.0% | na | na | na | na | na | na | na |
| Large Growth Avg | 3.7% | 15.7% | 29.7% | 38.9% | -32.1% | 20.4% | 42.3% | 33.2% | -0.7% | 29.8% | 2.7% |
| Risk Measures | |
| Standard Deviation: | 19.0% |
| Total Risk Index: | 1.55 - Above Average |
| Category Risk Index: | 1.03 - Above Average |
| Category Risk Grade: | D (76% Rank) |
| Beta: | 1.35 |
| R-Squared: | 86% |
| Leveraged Fund: | No |
| Inverse Fund: | No |
| Portfolio Characteristics | |
| Equity Investment Style: | Large-Cap Blend |
| Bond Investment Style: | na |
| Yield: | 4.5% |
| Dividend Distribution: | Annually |
| Cap Gains Distribution: | Annually |
| Total Assets: | $15 Mil |
| Fund Total Assets: | $ 15 Mil |
| Share Class Type: | |
| Portfolio Turnover: | 1555% |
Management Team
| Number of Managers: 5 | |||
| Longest Tenure: 4.5 years | |||
| Average Tenure: 1.6 years | |||
| Managers (Year): Cakmak Cengiz (2022), Mullen Christopher (2024), Duan Qiao (2024), Simon Adam (2026), Mikel Eli (2026) | |||
Portfolio Composition (as of 7/31/26)
| # of Holdings: | 44 |
| % in Top 10 Holdings: | 52.2% |
| Fund is Non-Diversified: | Yes |
| % in Foreign Issues: | 4.5% |
Portfolio Allocation |
|
| Domestic Stock: | 90.0% |
| Foreign Stock: | 4.5% |
| Preferred Stock: | 0.0% |
| Domestic Bond: | 0.1% |
| Foreign Bond: | 0.0% |
| Convertible Bond: | 0.0% |
| Other: | 4.6% |
| Cash: | 0.8% |
Purchase Information
| Fund Family: | Clockwise Capital LLC |
| Phone Number: | 800-610-6128 |
| Website: |
| Status: | Open |
| Inception Date: | January 27, 2022 |
| Min. Initial Purchase: | $ 0 |
| Min. Initial IRA Purchase: | $ 0 |
| True No-Load: | Yes |
| Front Load Maximum: | 0.00% |
| Deferred Charge Maximum: | 0.00% |
| Redemption Charge Maximum: | 0.00% |
| 12b-1 Fee: | na |
Expenses and Fees | |
| Expense Ratio (%): | 0.96% ( Rating : High ) |
| Category Average Expense Ratio (%): | 0.96% |
| Share Class: | Clockwise U.S. Core Equity ETF |
| Min. Subsequent Purchase: | $ 0 |
| Min. Subsequent IRA Purchase: | $ 0 |
Copyright 2026 American Association of Individual Investors and Morningstar, Inc. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.